Liquid Biopsy

Biotech Blogs

Natera on How MRD Testing Could Reshape Cancer Monitoring and Trial Design

Precision Oncology in Practice: Strategies to Drive the Next Generation of Oncology Studies

April 21, 2026
Biotech News

Advanced Biomed IPO Raises $6.56M Towards Liquid Biopsy Testing
Business & Finance News

Court Awards Guardant Almost $293M in False Advertising Lawsuit Against Natera Over Cancer Blood Tests

EHR Optimization and Decentralized Strategies for Clinical Performance Studies of Liquid Biopsy Technologies in Cancer Screening

December 18, 2024

Novel Liquid Biopsy ML multigene mRNA Expression for Clinical Trials: from Discovery to CDx Development

September 26, 2024

Unlocking precision medicine: An overview of Illumina’s TSO500

June 17, 2024
Biotech News

FoundationOne Liquid CDx Is a New Companion Diagnostic for Metastatic Colorectal Cancer

In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology

May 25, 2023
Biotech Blogs

The Utility of Liquid Biopsy in Oncology Clinical Trials

Liquid Biopsy Assays: Beyond Recurrence Detection in Post-Diagnosis Cancer Management

December 02, 2022

Emerging Applications for Liquid Biopsy in Drug Development

November 15, 2022

Liquid Biopsy in Oncology: Opportunities and Challenges

September 08, 2022

Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and Multianalyte Applications of Cell-Free RNA, DNA and CTCs

July 19, 2022
Diagnostics News

Cancer Blood Test Developed by University of Oxford Researchers Can Detect Metastasis
Blogs

COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test Ep. 23